Literature DB >> 28825904

Examining Progress and Equity in Information Received by Women Using a Modern Method in 25 Developing Countries.

Anrudh K Jain1.   

Abstract

CONTEXT: The information exchanged during a contraceptive visit is important because providers need to understand clients' reproductive intentions and clients need to receive adequate information about methods and possible method-related side effects and problems. Little is known about how information exchange has changed over time and how it might vary across countries or subgroups within a country.
METHODS: Demographic and Health Survey data from 25 developing countries were used to calculate the Method Information Index (MII), a Family Planning 2020 indicator that reflects some aspects of contraceptive information exchanged between providers and clients. For each country, the MII was calculated from each of two surveys about five years apart to examine change in the indicator over time. In addition, the MII was examined for all countries combined and by region.
RESULTS: The average MII for all 25 countries increased from 34% at the earlier survey time to 39% at the later survey time; the index values of individual countries ranged from 19% to 64% at survey time 1 and from 13% to 65% at survey time 2. The MII increased over time in 15 countries and declined in 10. In analyses by contraceptive method type, the MII tended to be highest among implant users and lowest among women relying on sterilization. The index was generally higher among women living in urban areas than among those in rural areas, and tended to rise with increases in women's education and household wealth.
CONCLUSIONS: On the basis of the MII, developing countries have room to improve information exchange between providers and clients. Such improvements would require concerted efforts by programs and donors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28825904     DOI: 10.1363/42e1616

Source DB:  PubMed          Journal:  Int Perspect Sex Reprod Health        ISSN: 1944-0391


  7 in total

1.  Quality of Long-acting Reversible Contraception Provision in Lomé, Togo.

Authors:  Karen Weidert; Koffi B Tekou; Ndola Prata
Journal:  Open Access J Contracept       Date:  2020-09-23

2.  Trend and determinants of quality of family planning counseling in Ethiopia: Evidence from repeated PMA cross-sectional surveys, (2014-2019).

Authors:  Bedilu Alamirie Ejigu; Assefa Seme; Linnea Zimmerman; Solomon Shiferaw
Journal:  PLoS One       Date:  2022-05-27       Impact factor: 3.752

3.  Adding a Question About Method Switching to the Method Information Index Is a Better Predictor of Contraceptive Continuation.

Authors:  Aparna Jain; Kumudha Aruldas; Elizabeth Tobey; Arupendra Mozumdar; Rajib Acharya
Journal:  Glob Health Sci Pract       Date:  2019-06-27

4.  Association Between the Quality of Contraceptive Counseling and Method Continuation: Findings From a Prospective Cohort Study in Social Franchise Clinics in Pakistan and Uganda.

Authors:  Nirali M Chakraborty; Karen Chang; Benjamin Bellows; Karen A Grépin; Waqas Hameed; Amanda Kalamar; Xaher Gul; Lynn Atuyambe; Dominic Montagu
Journal:  Glob Health Sci Pract       Date:  2019-03-29

5.  Sterilization regret in India: Is quality of care a matter of concern?

Authors:  Anjali Bansal; Laxmi Kant Dwivedi
Journal:  Contracept Reprod Med       Date:  2020-09-08

6.  Measuring quality of care at the community level using the contraceptive method information index plus and client reported experience metrics in Bangladesh.

Authors:  Sharif Hossain; Pooja Sripad; Brady Zieman; Shongkour Roy; Sarah Kennedy; Irfan Hossain; Ben Bellows
Journal:  J Glob Health       Date:  2021-03-10       Impact factor: 4.413

7.  Quality of Family Planning Counseling in Ethiopia: Trends and determinants of information received by female modern contraceptive users, evidence from national survey data, (2014- 2018).

Authors:  Gili Hrusa; Mark Spigt; Tariku Dejene; Solomon Shiferaw
Journal:  PLoS One       Date:  2020-02-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.